Undertaking for Non- Applicability of Regul;ation 32 of SEBI (LODR) Regulation 2015 for the quarter and financial year ended 31st March 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Johnson Pharmacare Ltd has submitted a compliance certificate to BSE stating that Regulation 32 of SEBI (LODR) Regulations 2015 is not applicable to the company. The regulation requires listed entities to disclose deviations in use of proceeds from public issues, rights issues, or preferential issues. The company certified that it did not undertake any share issuance via public issue, rights issue, preferential issue, or similar mechanisms during Q4 FY2026 or the full financial year ended March 31, 2026. The undertaking was signed by Nand Kishor Ray, Additional Director, and dated May 27, 2026.
No impact on shareholders or stock price. This is a routine negative confirmation filing indicating the company did not raise equity capital during the period, so no fund utilization disclosure is required.